期刊文献+

肝动脉化疗栓塞联合三维适形放疗治疗不能切除肝癌研究 被引量:4

A Study of Combined Therapy of Transcatheter Arterial Chemoembolization and Three Dimensional Conformal Radiotherapy for Unresectable Hepatocellular Carcinoma
下载PDF
导出
摘要 目的:探讨肝动脉化疗栓塞(TACE)联合三维适形放射治疗(3-DRCT)在治疗不能手术切除的原发性肝癌(HCC)的疗效。方法:将90例不能手术切除的HCC患者分为两组,实验组(B组)行1次TACE后再给以立体定向放疗,对照组(A组)根据病情给以TACE2-3次。比较两组肿瘤大小、AFP变化情况,并对1,2,3年生存率进行分析。结果:A组治疗前后平均肿瘤直径分别是(7.35±2.25)cm和(6.20±1.67)cm,B组分别是(7.65±1.86)cm和(6.18±1.74)cm,两组治疗前、后比较均有显著差异(t分别为2.681和3.891,P<0.005和P<0.001),但两组之间比较均没有显著差异(P>0.05)。两组治疗前后血清AFP水平比较两组均有明显下降,A组从2596.0 ng/L下降到246.9 ng/L(U=420,P<0.001),B组从2317.4 ng/L下降到64.6 ng/L(U=310.0,P<0.001)。两组之间比较,治疗后AFP差异有统计学意义(U=561.0,P<0.05)。两组中位生存期分别为18月和25月,1、2、3年生存率分别为:A组66.7%,42.2%和25%,B组为86.7%,55.6%和33.3%,两组比较差异有显著性意义(P=0.01)。结论:TACE联合3-DRCT治疗不能切除的HCC的疗效优于单纯TACE。 Objective:To evaluate the therapeutic effect of combined transcatheter arterial chemoembolization(TACE) and three dimensional conformal radiotherapy(3-DRCT) for hepatocellular carcinoma(HCC).Methods:Ninety patients with HCC were randomly divided into 2 groups.Forty-five patients(group A) received TACE(2-3 procedures) and other received treatment of combination of TACE(1 procedure) and 3-DRCT(group B,n=45).The tumor size and serum AFP level between the two groups were compared.The 1-,2-,3-year cumulative survival rates of the patients were analyzed.Results:The average diameter of tumor before and after treatment were(7.35±2.25)cm and(6.20±1.67)cm in group A respectively.The tumor diam-eter before and after treatment were(7.35±2.25)cm and(6.20±1.67)cm in group B respectively.There was statistically signifi-cant decrease in tumor size in both group A(t = 2.681,P 〈0.005) and group B(t = 3.891,P 〈0.001).There was no significant differences between the two groups in tumor response(P 〉0.05).Mean serum AFP level was significant decreased in group A(from 2596.0 ng/L to 246.9 ng/L) and group B(from 2317.4 ng/L to 64.6 ng/L).Significant differences was demonstracted be-tween the two groups after treatment(U = 561.0,P 〈0.05).The median survival period in group Aand B were 18 months and 25 months.The cumulate survival rate of 1,2 and 3-year were 66.7%,42.2% and 25% in group A and 86.7%,55.6% and 33.3% in group B.Significant differences was exhibited(P = 0.01).Conclusions:The therapeutic effect of TACE combined with 3-DRCT is better than single TACE in the treatment of unresectable HCC.
出处 《中国医学物理学杂志》 CSCD 2010年第5期2084-2086,共3页 Chinese Journal of Medical Physics
关键词 肝细胞癌 立体定向放射治疗 经导管动脉化疗栓塞术 hepatocellular carcinoma stereotactic radiotherapy transcatheter arterial chemoembolization
  • 相关文献

参考文献8

  • 1Lu W, Li YH, He XF, et al. Necrosis and apoptosis in hepatocellular carcinoma following low-dose versus high-dose preoperative chemoembolization[J].Cardiovasc Intervent Radiol. 2008,31 (6):1133- 1140.
  • 2梁世雄,蒋国梁,周振华,杨焕军,张小建,林钧华.肝癌介入治疗和三维适形放疗的临床Ⅰ/Ⅱ期试验[J].中国癌症杂志,2004,14(1):48-51. 被引量:20
  • 3汤钊猷著.临床肝癌治疗学[M].上海:上海科技教育出版社,2001,119-132.
  • 4Hawkins MA, Dawson LA. Badiation Therapy for Hepatocellular Carcinoma:From Palliation to Cure[J]. Cancer, 2006,106(8):1653-1663.
  • 5白光平,时启良,杨洲.全肝介入化疗加立体定向放疗治疗中晚期原发性肝癌效果分析[J].中华肿瘤防治杂志,2007,14(22):1736-1737. 被引量:1
  • 6Zhou ZH, Liu LM, Chen WW,et al. Combined therapy of transcatheter arterial chemoembolisation and three--dimensional conformal radiotherapy for hepatocellular carcinoma [J]. Br J Radiol. 2007,80(951): 194-201.
  • 7Robert son JM ,Lawrene TS ,Wolker S ,et al . The treatment of colorectal liver metastases with conformal radiation t herapy and regional Chemotherapy[J]. Int J RadiatOncol Biol Phys ,1995,32(2):445.
  • 8Robert son JM ,Lawrence TS ,Andrews J C ,et al . Long-term result of hepatic artery fluorodeoxyuridine and conformal radiation therapy for primary hepatobiliary cancers [J]. Int J Radiation Oncology Biol Phys, 1997,37(2):325.

二级参考文献11

共引文献19

同被引文献31

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部